Pier Capital’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.06M Buy
796,696
+224,841
+39% +$2.44M 1.49% 12
2025
Q4
$7.34M Sell
571,855
-91,357
-14% -$1.13M 1.17% 37
2025
Q3
$7.41M Sell
663,212
-31,023
-4% -$299K 1.16% 34
2025
Q2
$6.89M Buy
694,235
+200,244
+41% +$1.96M 1.05% 51
2025
Q1
$4.64M Buy
+493,991
New +$5.19M 0.78% 64

Other funds holding ANGO

Pier Capital's ANGO Position: Q1 2026 in Review

Pier Capital increased its AngioDynamics (ANGO) stake by 39% in Q1 2026, buying an estimated $2.44M and bringing the position to 796,696 shares worth $9.06M. The position accounts for 1.49% of the portfolio, ranked #12.

Pier Capital first reported a position in ANGO in Q1 2025 and has held it in 5 quarters since. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Pier Capital held 796,696 shares of AngioDynamics worth $9.06M as of Q1 2026.
  • Pier Capital bought 224,841 AngioDynamics shares in Q1 2026, an estimated $2.44M.
  • AngioDynamics made up 1.49% of Pier Capital's portfolio in Q1 2026, its #12 holding.
  • Pier Capital first reported a position in AngioDynamics in Q1 2025 and has held it in 5 quarters since.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Pier Capital's 13F filing for Q1 2026, filed 14 May 2026.